Spero Therapeutics (SPRO) Upgraded to Buy: Here's What You Should Know
Portfolio Pulse from
Spero Therapeutics (SPRO) has been upgraded to a Zacks Rank #2 (Buy) due to growing optimism about its earnings prospects. This upgrade suggests potential positive movement in SPRO's stock price.
January 15, 2025 | 6:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Spero Therapeutics has been upgraded to a Zacks Rank #2 (Buy), indicating positive sentiment towards its earnings prospects and potential upward movement in its stock price.
The upgrade to a Zacks Rank #2 (Buy) reflects increased optimism about Spero Therapeutics' earnings prospects. Such upgrades typically lead to positive investor sentiment and potential stock price increases.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100